novocure.com Report : Visit Site

Technical data of the novocure.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host novocure.com. Currently, hosted in United States and its service provider is Merit Network Inc. .

the related websites

innovationintextiles.com primeoncology.org btbuddies.org.uk wjso.com clinica.co.uk airframer.com 1stcontact-taxrefunds.com dailymail.co.uk theregister.co.uk bbc.com faceresearch.org asean.org 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

you are using an outdated browser. please upgrade your browser to improve your experience. we have revised our privacy policy that is in effect as of may 25, 2018. please click here to access it. search contact us careers news and media about us corporate timeline professor yoram palti founded novocure in 2000. we have since accomplished many significant milestones. leadership meet our leaders, who have extensive experience across oncology, biotechnology and medical device industries. corporate presentation we pioneer a profoundly different approach to treating cancer called tumor treating fields. our therapy our pipeline clinical trials our mechanism of action is broadly applicable across a variety of solid tumors. novocuretrial.com the science of tumor treating fields extends beyond glioblastoma. we are conducting clinical trials in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and mesothelioma. patient-forward news and media press releases press kits media gallery featured stories investor relations press releases corporate presentation events annual reports sec filings stock information corporate governance faq email alerts nasdaq: current stock price 45.05 1.75 last update 8/31/2018 careers working with us our locations current job listings ‘it's like an orchestra’ ori farber, senior medical manager, shares what it’s like to work behind the scenes on novocure’s company-sponsored clinical trials. learn more ‘they become like family’ matt lozano, a novocure senior device support specialist, shares the meaning he finds in working with patients and their caregivers. learn more a skilled communicator tomoe kamata, special project manager at novocure japan, uses her background in science and knack for interacting with people to market novocure’s cancer therapy in japan. learn more novocure honors brain tumor awareness month as a member of the brain cancer community, novocure took steps to support the initiative, raise awareness and encourage action. learn more mechanism of action mechanism of action tumor treating fields is a cancer therapy that uses electric fields tuned to specific frequencies to disrupt cell division, inhibiting tumor growth and causing affected cancer cells to die. join our team join our team we count on the contributions of our talented team members who are committed to improving the lives of cancer patients. news and media news and media see what we’ve been up to and access materials related to our company, our people and our therapy. press releases the story of novocure in 2000, our founder professor yoram palti sought to leverage his expertise in biophysics to develop a new way to treat cancer that would destroy tumor cells while sparing healthy tissue and avoiding many of the life-altering side effects of existing cancer therapies. novocure has grown into an international oncology company with more than 450 employees and operations in the u.s., europe and asia. learn more we can leverage physics to fight cancer tumor treating fields is a cancer therapy that uses electric fields tuned to specific frequencies to disrupt cell division, inhibiting tumor growth and causing affected cancer cells to die. our therapy explore our clinical pipeline our research shows that tumor treating fields have an antimitotic effect in more than 18 solid tumor types in culture and in eight in vivo tumor models. our pipeline we are dedicated to improving the lives of cancer patients patients remain at the heart of the work we do every day. learn more about our patients, their families and the people working to deliver patient-forward therapies to treat cancer. patient-forward about us corporate timeline leadership corporate presentation our therapy our pipeline clinical trials novocuretrial.com patient-forward news and media press releases press kits media gallery featured stories investor relations press releases corporate presentation events annual reports sec filings stock information corporate governance faq email alerts careers working with us our locations current job listings corporate responsibility website privacy policy hipaa privacy notice gdpr patient privacy notice terms and conditions site map © 2018 novocure - all rights reserved cookie policy this website intends to use cookies to improve the site and your experience. by continuing to browse the site you are agreeing to accept our use of cookies. if you require further information and/or do not wish to have cookies placed when using the site, review the cookies section of our website privacy policy or visit www.allaboutcookies.org . about us corporate timeline professor yoram palti founded novocure in 2000. we have since accomplished many significant milestones. leadership meet our leaders, who have extensive experience across oncology, biotechnology and medical device industries. corporate presentation we pioneer a profoundly different approach to treating cancer called tumor treating fields. our therapy our pipeline clinical trials our mechanism of action is broadly applicable across a variety of solid tumors. novocuretrial.com the science of tumor treating fields extends beyond glioblastoma. we are conducting clinical trials in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and mesothelioma. patient-forward news and media press releases press kits media gallery featured stories investor relations press releases corporate presentation events annual reports sec filings stock information corporate governance faq email alerts careers working with us our locations current job listings

URL analysis for novocure.com

https://www.novocure.com/about-us/
https://www.novocure.com/investor-relations/#press-releases
https://www.novocure.com/corporate-governance/
https://www.novocure.com/contact/
https://www.novocure.com/stock-information/
https://www.novocure.com/investor-relations/#email-alerts
https://www.novocure.com/privacy-policy/
https://www.novocure.com/compliance-plan/
https://www.novocure.com/our-pipeline
https://www.novocure.com/mechanism-of-action/
https://www.novocure.com/news-and-media/
https://www.novocure.com/leadership/
https://www.novocure.com/features/tomoe-kamata-special-project-manager
https://www.novocure.com/press-releases
https://www.novocure.com/feature-stories/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: NOVOCURE.COM
Registry Domain ID: 90283583_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.domainthenet.com
Registrar URL: http://www.DomainTheNet.com
Updated Date: 2016-11-06T08:53:07Z
Creation Date: 2002-09-15T05:19:17Z
Registry Expiry Date: 2022-09-15T05:20:14Z
Registrar: Domain The Net Technologies Ltd.
Registrar IANA ID: 10007
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: 972-3-7600500
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.DTNT.INFO
Name Server: NS2.DTNT.INFO
Name Server: NS3.DTNT.INFO
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-10-11T14:59:41Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Domain The Net Technologies Ltd.

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =novocure.com

  PORT 43

  TYPE domain

DOMAIN

  NAME novocure.com

  CHANGED 2016-11-06

  CREATED 2002-09-15

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  NS1.DTNT.INFO 62.219.91.139

  NS2.DTNT.INFO 62.219.91.150

  NS3.DTNT.INFO 52.36.225.219

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .